CD69-induced monocyte apoptosis involves multiple nonredundant signaling pathways

被引:22
作者
Ramirez, R [1 ]
Carracedo, J [1 ]
Castedo, M [1 ]
Zamzami, N [1 ]
Kroemer, G [1 ]
机构
[1] CNRS UPR420,F-94801 VILLEJUIF,FRANCE
基金
澳大利亚研究理事会;
关键词
D O I
10.1006/cimm.1996.0232
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Simultaneous stimulation of human monocytes/macrophages or THP1 cells with LPS and an antibody specific for the activation marker CD69 induces apoptosis. Here we demonstrate the involvement of multiple independent signals that are necessary for apoptosis induction, Thus, inhibitors of phospholipase Az and lipoxygenase prevent apoptosis induction. Similarly, the ADP-ribosylating G-protein-reactive pertussis toxin (PTX) but not a mutant toxin lacking the ADP-ribosylating moiety (mPTX) prevents apoptosis induction. Furthermore, inhibition of NO generation abrogates completely the induction of apoptosis by LPS/CD69 ligation. These three pathways can be dissociated from each other in the sense that interventions on the arachidonic acid metabolism or G proteins do not inhibit the generation of NO and that exogenous NO cannot reverse the inhibition of cell death by inhibitors of phospholipase A(2) or PTX. In addition, both PTX and mPTX affect arachidonic acid mobilization only partially, indicating that the apoptosis-inhibitory effect of PTX (which is not shared by mPTX) cannot be explained by its effect on phospholipase A(2) activation. Both I,PS and anti-CD69 are sufficient on their own to activate cells, as determined by TNF production, NO generation, or arachidonic acid metabolism, but neither LPS nor anti-CD69 can induce apoptosis on their own. Thus, apoptosis induction in this system involves at least three independent signal transduction systems-(i) arachidonic acid metabolism, (ii) NO, and (iii) PTX-sensitive events-each of which is necessary but insufficient to induce monocyte/macrophage apoptosis. These findings underline the complex control of activation-induced apoptosis in cells of the myelomonocytic lineage. (C) 1996 Academic Press, Inc.
引用
收藏
页码:192 / 199
页数:8
相关论文
共 44 条
[31]  
Rawadi G, 1996, J IMMUNOL, V156, P670
[32]   A MUTANT PERTUSSIS TOXIN MOLECULE THAT LACKS ADP-RIBOSYLTRANSFERASE ACTIVITY, PT-9K/129G, IS AN EFFECTIVE MUCOSAL ADJUVANT FOR INTRANASALLY DELIVERED PROTEINS [J].
ROBERTS, M ;
BACON, A ;
RAPPUOLI, R ;
PIZZA, M ;
CROPLEY, I ;
DOUCE, G ;
DOUGAN, G ;
MARINARO, M ;
MCGHEE, J ;
CHATFIELD, S .
INFECTION AND IMMUNITY, 1995, 63 (06) :2100-2108
[33]   EXPRESSION OF THE EARLY LYMPHOCYTE-ACTIVATION ANTIGEN CD69, A C-TYPE LECTIN, IS REGULATED BY MESSENGER-RNA DEGRADATION ASSOCIATED WITH AU-RICH SEQUENCE MOTIFS [J].
SANTIS, AG ;
LOPEZCABRERA, M ;
SANCHEZMADRID, F ;
PROUDFOOT, N .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (08) :2142-2146
[34]   STRUCTURE OF THE GENE CODING FOR THE HUMAN EARLY LYMPHOCYTE-ACTIVATION ANTIGEN CD69 - A C-TYPE LECTIN RECEPTOR EVOLUTIONARILY RELATED WITH THE GENE FAMILIES OF NATURAL-KILLER CELL-SPECIFIC RECEPTORS [J].
SANTIS, AG ;
LOPEZCABRERA, M ;
HAMANN, J ;
STRAUSS, M ;
SANCHEZMADRID, F .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (07) :1692-1697
[35]  
SOLARY E, 1994, LEUKEMIA, V8, P792
[36]   CD-69 EXPRESSION DURING SELECTION AND MATURATION OF CD4+8+ THYMOCYTES [J].
SWAT, W ;
DESSING, M ;
VONBOEHMER, H ;
KISIELOW, P .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (03) :739-746
[37]   BACTERIAL LIPOPEPTIDES INDUCE NITRIC-OXIDE SYNTHASE AND PROMOTE APOPTOSIS THROUGH NITRIC OXIDE-INDEPENDENT PATHWAYS IN RAT MACROPHAGES [J].
TERENZI, F ;
DIAZGUERRA, MJM ;
CASADO, M ;
HORTELANO, S ;
LEONI, S ;
BOSCA, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (11) :6017-6021
[38]   THE CD69 RECEPTOR - A MULTIPURPOSE CELL-SURFACE TRIGGER FOR HEMATOPOIETIC-CELLS [J].
TESTI, R ;
DAMBROSIO, D ;
DEMARIA, R ;
SANTONI, A .
IMMUNOLOGY TODAY, 1994, 15 (10) :479-483
[39]  
TESTI R, 1989, J IMMUNOL, V143, P1123
[40]   APOPTOSIS AND DNA FRAGMENTATION PRECEDE TNF-INDUCED CYTOLYSIS IN U937 CELLS [J].
WRIGHT, SC ;
KUMAR, P ;
TAM, AW ;
SHEN, NP ;
VARMA, M ;
LARRICK, JW .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1992, 48 (04) :344-355